3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Breast Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Cyclophosphamide
29
Rituximab
25
fludarabine
15
fludarabine phosphate
13
Specimen Handling
12
obinutuzumab
10
ibrutinib
10
Magnetic Resonance Spectroscopy
10
Prednisone
9
Doxorubicin
9
Mycophenolic Acid
8
Etoposide
8
tocilizumab
7
polatuzumab vedotin
7
X-Rays
7
Whole-Body Irradiation
7
Phantoms, Imaging
7
Lenalidomide
7
Biopsy
7
glofitamab
6
Vincristine
6
Melphalan
6
Busulfan
6
Bendamustine Hydrochloride
6
venetoclax
5
pirtobrutinib
5
acalabrutinib
5
Peripheral Blood Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
Nivolumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
trastuzumab biosimilar HLX02
×
90 days
×
Clear all
No trials found.